• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结比率可预测甲状腺乳头状癌的复发。

Lymph node ratio predicts recurrence in papillary thyroid cancer.

机构信息

Department of Surgery, University of Wisconsin, K3/739 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792, USA.

出版信息

Oncologist. 2013;18(2):157-62. doi: 10.1634/theoncologist.2012-0240. Epub 2013 Jan 23.

DOI:10.1634/theoncologist.2012-0240
PMID:23345543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3579599/
Abstract

BACKGROUND

Lymph node metastasis occurs in 20%-50% of patients presenting for initial treatment of papillary thyroid cancer (PTC). The significance of lymph node metastases remains controversial, and the aim of this study is to determine how the lymph node ratio (LNR) may predict the likelihood of disease recurrence.

METHODS

We conducted a retrospective review of patients undergoing total thyroidectomy for PTC at our institution from 2005 to 2010. A total LNR (positive nodes to total nodes) and central lymph node ratio (cLNR) was calculated. Regression was used to determine a threshold LNR that best predicted recurrence. Multivariate logistic regression then determined the influence of LNR on recurrence while accounting for other known predictors of recurrence. Kaplan-Meier analysis and the log-rank test were used to compare differences in disease-free survival.

RESULTS

Of the 217 patients undergoing total thyroidectomy for PTC, 69 patients had concomitant neck dissections. Sixteen (23.2%) patients developed disease recurrence. When disease-free survival functions were compared, we found that patients with a total LNR ≥0.7 (p < .01) or a cLNR ≥0.86 (p = .04) had significantly worse disease-free survival rates than patients with ratios below these threshold values. Considering other known predictors of recurrence, we found that LNR was significantly associated with recurrence (odds ratio: 19.5, 95% confidence interval: 4.1-22.9; p < .01).

CONCLUSIONS

Elevated total LNR and cLNR are strongly associated with recurrence of PTC after initial operation. LNR in PTC is a tool that can be used to determine the likelihood of the patient developing recurrent disease and inform postoperative follow-up.

摘要

背景

在接受初始治疗的甲状腺乳头状癌(PTC)患者中,有 20%-50%发生淋巴结转移。淋巴结转移的意义仍存在争议,本研究旨在确定淋巴结比率(LNR)如何预测疾病复发的可能性。

方法

我们对 2005 年至 2010 年在我院接受甲状腺全切除术治疗 PTC 的患者进行了回顾性研究。计算总 LNR(阳性淋巴结与总淋巴结的比值)和中央淋巴结比率(cLNR)。使用回归确定最佳预测复发的 LNR 阈值。然后,多变量逻辑回归确定 LNR 对复发的影响,同时考虑了复发的其他已知预测因素。使用 Kaplan-Meier 分析和对数秩检验比较无病生存率的差异。

结果

在 217 例接受甲状腺全切除术治疗 PTC 的患者中,有 69 例同时进行了颈部清扫术。16 例(23.2%)患者发生疾病复发。当比较无病生存函数时,我们发现总 LNR≥0.7(p<0.01)或 cLNR≥0.86(p=0.04)的患者无病生存率明显低于比值低于这些阈值的患者。考虑到复发的其他已知预测因素,我们发现 LNR 与复发显著相关(优势比:19.5,95%置信区间:4.1-22.9;p<0.01)。

结论

初始手术后,升高的总 LNR 和 cLNR 与 PTC 的复发密切相关。LNR 是一种可用于确定患者发生复发性疾病可能性并为术后随访提供信息的工具。

相似文献

1
Lymph node ratio predicts recurrence in papillary thyroid cancer.淋巴结比率可预测甲状腺乳头状癌的复发。
Oncologist. 2013;18(2):157-62. doi: 10.1634/theoncologist.2012-0240. Epub 2013 Jan 23.
2
Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.预测甲状腺乳头状癌复发的淋巴结比率的最佳临界值
Medicine (Baltimore). 2016 Feb;95(5):e2692. doi: 10.1097/MD.0000000000002692.
3
Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.淋巴结比率可预测儿童乳头状甲状腺癌的复发情况。
J Pediatr Surg. 2019 Jan;54(1):129-132. doi: 10.1016/j.jpedsurg.2018.10.010. Epub 2018 Oct 5.
4
Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.甲状腺乳头状癌中淋巴结检出数和淋巴结比率的预后意义。
Thyroid. 2013 Jul;23(7):811-6. doi: 10.1089/thy.2012.0460. Epub 2013 Jun 21.
5
Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.颈侧区淋巴结转移的儿童甲状腺癌中预测复发风险的淋巴结比值和转移淋巴结大小的最佳值。
J Pediatr Surg. 2023 Mar;58(3):568-573. doi: 10.1016/j.jpedsurg.2022.07.010. Epub 2022 Jul 13.
6
Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.消融术前刺激甲状腺球蛋白比淋巴结比率更能预测病理N1a期甲状腺乳头状癌的复发。
Int J Clin Oncol. 2016 Oct;21(5):862-868. doi: 10.1007/s10147-016-0956-2. Epub 2016 Feb 2.
7
How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.需要切除多少个淋巴结?淋巴结比值小于 1/3 可降低甲状腺乳头状癌的淋巴结复发率。
Laryngoscope. 2022 Sep;132(9):1883-1887. doi: 10.1002/lary.30084. Epub 2022 Mar 1.
8
Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.甲状腺乳头状癌患者预防性中央区颈清扫术后,中央区淋巴结比值是局部区域复发的重要预测指标。
Ann Surg Oncol. 2014 Jan;21(1):277-83. doi: 10.1245/s10434-013-3258-1. Epub 2013 Sep 5.
9
Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.评估中央淋巴结比值在预测 N1a 低-中危甲状腺乳头状癌复发中的作用。
Front Endocrinol (Lausanne). 2023 Sep 14;14:1158826. doi: 10.3389/fendo.2023.1158826. eCollection 2023.
10
Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.伴有侧颈淋巴结转移的甲状腺乳头状癌复发:预测因素及手术治疗
Surgery. 2016 Mar;159(3):755-62. doi: 10.1016/j.surg.2015.08.033. Epub 2015 Oct 2.

引用本文的文献

1
Novel prediction nomogram model for recurrent/persistent disease versus the American thyroid association recurrence risk stratification in patients with N1b papillary thyroid cancer: a retrospective cohort study.N1b 型甲状腺乳头状癌患者复发性/持续性疾病的新型预测列线图模型与美国甲状腺协会复发风险分层的比较:一项回顾性队列研究
BMC Cancer. 2025 Aug 5;25(1):1271. doi: 10.1186/s12885-025-14742-4.
2
Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection.病理性转移性淋巴结密度(ND)可预测甲状腺乳头状癌患者根治性切除术后的早期复发。
Gland Surg. 2025 May 30;14(5):897-911. doi: 10.21037/gs-2025-36. Epub 2025 May 15.
3
Continuing De-escalation Trends: Is Adjuvant Radioactive Iodine Administration Truly Needed for Papillary Thyroid Carcinoma with Limited Cervical Disease?持续的降阶梯趋势:对于颈部疾病有限的乳头状甲状腺癌,辅助性放射性碘治疗真的有必要吗?
Ann Surg Oncol. 2025 Mar;32(3):1406-1407. doi: 10.1245/s10434-024-16590-1. Epub 2024 Dec 12.
4
Prediction of lateral lymph node metastasis with short diameter less than 8 mm in papillary thyroid carcinoma based on radiomics.基于放射组学的甲状腺乳头状癌短径小于 8mm 预测侧颈部淋巴结转移
Cancer Imaging. 2024 Nov 15;24(1):155. doi: 10.1186/s40644-024-00803-7.
5
Utility of Lymph Node Ratio in Predicting Biochemical Incomplete Clinical Response in Patients with Papillary Ca thyroid with Positive Neck Node.淋巴结比率在预测颈部淋巴结阳性的甲状腺乳头状癌患者生化不完全临床反应中的应用
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4043-4049. doi: 10.1007/s12070-024-04777-7. Epub 2024 Jun 6.
6
Recurrent Middle Eastern Differentiated Thyroid Carcinoma Has Worse Outcomes Than Persistent Disease.复发性中东分化型甲状腺癌的预后比持续性疾病更差。
J Clin Med. 2024 Mar 25;13(7):1877. doi: 10.3390/jcm13071877.
7
Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.促甲状腺激素受体(TSHR)作为分化型甲状腺癌成像的靶点。
Surgery. 2024 Jan;175(1):199-206. doi: 10.1016/j.surg.2023.05.045. Epub 2023 Oct 31.
8
Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension.分化型甲状腺癌伴甲状腺外侵犯手术范围的当代趋势
Am J Surg. 2024 Feb;228:173-179. doi: 10.1016/j.amjsurg.2023.09.021. Epub 2023 Sep 15.
9
The impact of lymph node ratio on disease recurrence in papillary thyroid microcarcinoma.淋巴结比率对甲状腺微小乳头状癌疾病复发的影响。
Ann R Coll Surg Engl. 2023 Sep;105(7):632-638. doi: 10.1308/rcsann.2022.0094.
10
Patient perspectives on barriers to obtaining surgery for primary hyperparathyroidism: A qualitative review.患者对甲状旁腺功能亢进症手术障碍的看法:定性综述。
Am J Surg. 2024 Feb;228:122-125. doi: 10.1016/j.amjsurg.2023.08.021. Epub 2023 Aug 23.

本文引用的文献

1
Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension.具有颈部淋巴结转移的甲状腺乳头状癌可以通过致癌 BRAF、淋巴结转移的数量和淋巴结外侵犯进行分层,以达到具有临床意义的预后分类。
Thyroid. 2012 Jun;22(6):575-84. doi: 10.1089/thy.2011.0431. Epub 2012 Apr 3.
2
Preoperative ultrasonography findings predict the need for repeated surgery in papillary thyroid cancer.术前超声检查结果可预测甲状腺乳头状癌患者需要再次手术。
Endocr Pract. 2012 May-Jun;18(3):403-9. doi: 10.4158/EP11221.OR.
3
Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases.验证淋巴结比率在皮肤黑色素瘤患者中的预后价值:基于人群的 8177 例病例研究。
Surgery. 2011 Jul;150(1):83-90. doi: 10.1016/j.surg.2011.02.021.
4
Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.接受放射性碘治疗的低危(T1N0)甲状腺癌患者中第二癌症发病率上升。
Cancer. 2011 Oct 1;117(19):4439-46. doi: 10.1002/cncr.26070. Epub 2011 Mar 22.
5
Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.预防性中央区淋巴结清扫术对甲状腺乳头状癌术后甲状腺球蛋白水平和放射性碘治疗的影响。
Surgery. 2010 Dec;148(6):1100-6; discussion 1006-7. doi: 10.1016/j.surg.2010.09.019.
6
The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008.放射性碘治疗低危甲状腺癌的疗效:对 1966 年至 2008 年 4 月同行评议文献的系统分析。
Thyroid. 2010 Nov;20(11):1235-45. doi: 10.1089/thy.2009.0455.
7
Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values.临床无病且血清甲状腺球蛋白值不可测或极低的患者中的甲状腺癌复发。
J Clin Endocrinol Metab. 2010 Dec;95(12):5241-8. doi: 10.1210/jc.2010-1500. Epub 2010 Sep 15.
8
An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma.高分化甲状腺癌中淋巴结获取量及淋巴结比率的评估
Am Surg. 2010 Jan;76(1):28-32.
9
Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer.新诊断和复发性/残留甲状腺癌的手术治疗争议。
Thyroid. 2009 Dec;19(12):1373-80. doi: 10.1089/thy.2009.1606.
10
The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma.甲状腺乳头状癌预防性中央区淋巴结清扫术的利弊
Thyroid. 2009 Jul;19(7):683-9. doi: 10.1089/thy.2009.1578.